Photoactive immunoconjugate of hematoporphyrin with antibodies against vascular endothelial growth factor: Preparation, physicochemical and biological properties

Biopolymers and Cell

Volumn 25, Issue 1, 2009, Pages 56-61

  Lisniak, I O ^a   Novichenko, N L ^a   Mamchur, A A ^a   Gamalia, M F ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Angiogenesis; Conjugates; Hematoporphyrin; Photodynamic therapy; VEGF

Indexed keywords

ANTIBODY CONJUGATE; HEMATOPORPHYRIN; PORPHYRIN; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ARTICLE; CONJUGATION; EMBRYO MEMBRANE; NONHUMAN; PHOTOACTIVATION; PHYSICAL CHEMISTRY;

EID: 65949117054     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.0007CB     Document Type: Article

References (15)

1. Mew D., Wat C. K., Towers G. H., Levy J. C. Photoimmunotherapy treatment of animal tumors with tumo-specific monoclonal antibody-hematoporphyrin conjugates. J. Jmmunol 1983 130, N 3 P. 1473-1477.
2. Jiang F. N., Richter A. M., Jain A. K., Levy J. G., Smith C. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A 549-tumor-bearing nude mice. Biotechnol. Ther 1993 4, N 1-2 P. 43-61.
3. Carcenac M., Larrogue C., Langlois R., van Lier J., Artus J., Pelegrin A. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates. J. Photochem. Photobiol 1999 70, N 6 P. 930-936.
4. Vrouenraets M. B., Visser G. W., Stigter M., Oppelaar H., Snow G. B, van Dongen G. A. Comparison of aluminium (III) phthalocyanine tetrasulfonate-and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro. Int. J. Cancer 2002 98, N 5 P. 793-798.
5. Fabbrini M., Trachsel E., Soldani P., Bindi S., Alessi P., Bracci L., Kosmehl H., Zardi L., Neri D., Neri P. Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate. Int. J. Cancer 2006 118, N 7 P. 1805-1813.
6. Sharman W. M., van Lier J. E., Allen C. M. Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug Deliv. Rev 2004 56, N 1 P. 53-76.
7. Governatore M., Hamblin M. R., Shea C. R., Rizvi I., Molpus K. G., Tanabe K. K., Hasan T. Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1 A chlorin e6 immunoconjugate. Cancer Res 2000 60 P. 4200-4205.
8. Linares R., Racheco Y. R., Good T. A. Efficacy of different targeting agents in the photolysis of interleukine-2 receptor bearing cells. J. Photochem. Photobiol 2004 77, N 1-3 P. 17-26.
9. Giysene A., Missiaen L., Wilfried M., Witte P. Epidermal growth factor-mediated targeting of chlorine e6 selectively potentiates its photodynamic activity. Cancer Res 2000 60, N 8 P. 2197-2202.
10. Savellano M., Pogue B., Hoopes P., Vitetta E., Paulsen K. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpessing cancer cells with pyropheophorbide-immunoconjigates. Cancer Res 2005 65, N 14 P. 6371-6379.
11. Soukos N., Hamblin M., Keel S., Fabian R., Deutsch T., Hasan T. Epidermal growth factor receptor-targeting immunophotodiagnosis and photoimmunotheraphy of oral precancer in vivo. Cancer Res 2001 61, N 11 P. 4490-4496.
12. Gijsens A., De Witte P. Targeting of chlorine E6 by EGF increasing its photodynamic activity in selective ways. Verth. K Acad. Geneeskd. Belg 2000 62, N 4 P. 329-352.
13. Gupta S., Mishra A. K., Muralidhar K., Jain V. Improved targeting of photosensitizers by intratumoral administration of immunoconjugates. Technol. Cancer Res. Treat 2004 3, N 3 P. 295-301.
14. Chen B., Pogue B. W., Luna J. M., Hardman R. L., Hoopes P. J., Hasan T. Tumor vascular permeabilization by vasculartargeting photosensitization: effects, mechanism, and therapeutic implications. Clin. Cancer Res 2006 12, N 3 P. 917-923.
15. Roberts W., Hasan T. Role of neovascularization and vascular permeability on the tumor retention of photodynamic agents. Cancer Res 1992 52, N 4 P. 924-930.